VAK-694

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameVAK-694
Drug Alias NameNVP-VAK-694VAK-694
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-4 inhibitors
TargetsInterleukin-4
Therapy Area/IndicationsRhinitis, Allergic, SeasonalRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsRhinitis, Allergic, SeasonalRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A